FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 358:1868-1869 April 24, 2008 Number 17 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Belmaker, R.H. PubMed Citation

To the Editor: In their review article, Belmaker and Agam (Jan. 3 issue)¹ examine several mechanisms involved in depressive disorders, but they do not mention evidence that androgen-deprivation therapy, which is frequently used in the management of prostate cancer, can cause major depression.² The mechanisms underlying this association may include loss of sexual potency, fatigue, cognitive impairment, and changes in body composition, which lead to deterioration of a patient's perception of his body.³ A direct effect of testosterone, however, cannot be ruled out. A cross-sectional study of the relation between testosterone levels and depressive symptoms in 856 community-dwelling older men . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.